US8801764B2 - Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity - Google Patents

Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity Download PDF

Info

Publication number
US8801764B2
US8801764B2 US11/415,782 US41578206A US8801764B2 US 8801764 B2 US8801764 B2 US 8801764B2 US 41578206 A US41578206 A US 41578206A US 8801764 B2 US8801764 B2 US 8801764B2
Authority
US
United States
Prior art keywords
treatment
flaccidity
area
reducing localized
lipodystrophies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US11/415,782
Other languages
English (en)
Other versions
US20060253112A1 (en
Inventor
Danilo Castro Suarez
Wolfgang Neuberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biolitec AG
Original Assignee
Biolitec Pharma Marketing Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolitec Pharma Marketing Ltd filed Critical Biolitec Pharma Marketing Ltd
Assigned to CERAMOPTEC INDUSTRIES, INC. reassignment CERAMOPTEC INDUSTRIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NEUBERGER, WOLFGANG, SUAREZ, DANILO CASETRO
Priority to US11/415,782 priority Critical patent/US8801764B2/en
Priority to CN2006800154094A priority patent/CN101170959B/zh
Priority to BRPI0610986A priority patent/BRPI0610986B8/pt
Priority to CA2606772A priority patent/CA2606772C/en
Priority to MX2007013851A priority patent/MX2007013851A/es
Priority to ES06759003.4T priority patent/ES2533205T3/es
Priority to EP06759003.4A priority patent/EP1912583B1/en
Priority to KR1020077026969A priority patent/KR20080006623A/ko
Priority to PCT/US2006/017027 priority patent/WO2006121734A1/en
Priority to JP2008510177A priority patent/JP2009502212A/ja
Publication of US20060253112A1 publication Critical patent/US20060253112A1/en
Assigned to BIOLITEC PHARMA MARKETING LTD. reassignment BIOLITEC PHARMA MARKETING LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOLITEC, INC.
Assigned to BIOLITEC, INC. reassignment BIOLITEC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CERAMOPTEC INDUSTRIES, INC.
Priority to US14/282,117 priority patent/US20150005751A1/en
Publication of US8801764B2 publication Critical patent/US8801764B2/en
Application granted granted Critical
Assigned to BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG reassignment BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOLITEC PHARMA MARKETING LTD.
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00792—Plastic surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/00458—Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
    • A61B2018/00464—Subcutaneous fat, e.g. liposuction, lipolysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255—Optical elements at the distal end of probe tips
    • A61B2018/2272—Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam

Definitions

  • U.S. Pat. No. 5,807,385 by Keller, titled Method of Laser Cosmetic Surgery discloses cosmetic laser surgery for eliminating wrinkles, frowns, and folds, for example.
  • a quartz fiber is inserted into the skin and laser radiation in the range from 532 to 1060 nm is noted with a preferred wavelength of 532 nm.
  • the use of various medical devices for removing wrinkles and other unwanted features such as hooks, retractors, bivalve speculum, etc., is noted.
  • U.S. Pat. No. 6,206,873 by Paolini, et al., titled, “Device and Method for Eliminating Adipose Layers by Means of Laser Energy,” discloses a hollow needle with an optical fiber in the center.
  • the fat tissues, adipose cells are liquidized when the cell walls are broken. The fluid is removed by suction through the needle.
  • Laser wavelength range is noted as from 0.75 to 2.5 microns but a preferred wavelength of 1.06 is called out.
  • a rounded optical fiber end is shown in FIG. 3 beyond the needle end.
  • Paolini et al. use a Nd:YAG type of laser and note a wavelength range above.
  • the liquid produced may be removed from the body by normal absorption, etc. Col. 4, lines 32 to 39.
  • the laser light is applied externally and suction by cannula or hypodermic needle may be used to remove the lipid tissue that has been destroyed and formed into liquid.
  • Col. 12 lines 30 to 55.
  • cooling to the skin tissue is noted.
  • the danger of using internal laser energy to remove fat tissue is noted on Col. 6, lines 50 to 64, because of the high power required.
  • It is at least one aim of the present invention is to provide a method of cosmetic surgery using laser radiation from a high power source to quickly heat targeted tissue for destruction.
  • the present invention provides a method and device for cosmetic surgery, especially fat reduction and collagen reformation, by means of a high power laser operating at about 980 nm.
  • the cosmetic surgery method substantially reduces or removes localized lipodystrophies, and essentially reduces flaccidity by localized laser heating of adipose tissue using an optical fiber inserted into a treatment area.
  • the method and device are particularly well suited for treating Lipodystrophies with flaccidity
  • High power laser energy is applied to “fat” cells to breakdown the cell walls releasing the cell fluid.
  • the laser radiation is applied through an optical fiber which may be held within a catheter-like device having a single lumen.
  • the optical fiber may have a diffuser mounted on the tip to further apply heating to tissues surrounding the whole tip.
  • a saline solution may also be inserted into the treatment site to aid in the heating of the fat cells and their eventual destruction as well as their removal.
  • the pool of cell fluid in the area of treatment is removed by a combination of techniques including allowing the body to remove it by absorption and drainage from the entry sites thus minimizing trauma to the area of treatment and hastening recovery. Additional techniques to remove the cell fluid include direct force application by means of elastic bandages and external suction applied to the entry sites. Quick and lasting cosmetic changes, even in areas having prior untreatable fat tissues, are achieved while minimizing trauma to the treatment areas.
  • FIGS. 1A and 1B illustrate by photographs the before and after appearance of lower eyelids treated by the method and device of the present invention as an example of the effective treatment provided by the present invention.
  • FIG. 2 illustrates by schematic, devices of the present invention.
  • FIGS. 3A and 3B illustrate by a cross sectional elevational view, two different embodiments of the needle like device of the present invention.
  • FIG. 4 illustrates by a cross sectional elevational view, an optical fiber in a cannula for the present invention.
  • FIGS. 5A and 5B illustrate by photographs the before and after appearance of the dorsal area treated by the method and device of the present invention as an example of the effective treatment provided by the present invention.
  • FIGS. 6A and 6B illustrate by photographs the before and after appearance of the external side of the thigh treated by the method and device of the present invention as an example of the effective treatment provided by the present invention.
  • FIGS. 7A to 7F illustrate different devices for the application of laser radiation and the removal of liquid from the area of treatment.
  • the present invention describes a method and device for cosmetic surgery by means of a high power laser operating at about 980 nm.
  • the cosmetic surgery method substantially reduces or removes localized lipodystrophies and/or flaccidity by localized heating of adipose tissue by means of an optical fiber inserted into an area of treatment.
  • the high power laser energy is applied to heat the “fat” cells to a temperature wherein the cell walls break releasing the cell fluid.
  • the laser radiation is applied by an optical fiber and the optical fiber may be held within a catheter-like device having a single lumen therein.
  • the optical fiber may have a diffuser mounted on the tip to facilitate heating tissues surrounding the whole tip.
  • a saline solution is infused into the treatment site.
  • the pool of cell fluid in the area of treatment may be removed by a combination of techniques including allowing the body to eliminate it by absorption and/or removal, drainage from the entry sites thus minimizing trauma to the area of treatment, direct force application by means of elastic bandages and external suction applied to the entry sites.
  • the method and devices of the present invention provide for quick and lasting cosmetic changes in areas having prior untreatable fat tissues while at the same time minimizing trauma to the areas of treatment.
  • the technique uses a 15 w-980 nm diode laser to rid the patient of aesthetically unpleasing fat and reduce flaccidity on different parts of the body, especially in areas that are resistant to change by dieting and exercising.
  • Each adiposite has a fat content which is emulsified by the laser action and then absorbed and eliminated via lymphatic system.
  • Lipids are formed by a Glycerol chain and 3 units of 3-fatty acids. Heat dissociates the lipids and glycerol is expelled by urine. 3-fatty acids as energy units are easily used by the body and as other poly-unsaturated oils are eliminated via lymphatic (which can take a few weeks) and hepatic systems. In contrast with liposuction and its modifications, this method preserves the structural tissues, acting only on the fat cells.
  • the procedures followed in the present invention are as follows: The area of treatment is marked to differentiate by depth and approximate volume (cm 3 ) of excess adipose tissues.
  • the area of treatment is (sterilized) disinfected.
  • the insertion sites are marked.
  • the patient is placed on sterile surrounding and local anesthesia is applied to the skin where there are going to be insertion sites.
  • a small entry is made and the site is widened and pre-tunneled into the subcutaneous tissue by using a small, curved hemostat.
  • a blunt infusion catheter is then inserted via this tunnel into the site, and tumescent anesthetic is delivered first to the deepest layer in a radial fashion and then successively more superficially. Infiltration of the anesthetic is then achieved by pump.
  • a needle is selected according to the fiber diameter and inserted (e.g., 18 G French for 600 um fibers on large areas and 25 G French with a 220 um fiber for face treatments) and a sterile optical fiber is then inserted.
  • the appropriate treatment mode and the parameters of the laser are selected, e.g., as in Table 1.
  • the position of the fiber tip is controlled by the laser aiming beam.
  • the pre-selected energy is applied and the fiber is moved to treat the desired area.
  • Ultrasound guidance can be used to position the tip of the fiber. After all of the entry sites are treated, ultrasound and lymphatic drainage post-procedures are followed. Elastic bandage is placed on the treated area for 3 to 5 days.
  • This treatment preserves the structural tissues and elasticity of the skin with the addition of localized retraction and firming of the area. This reduces flaccidity by up to 50%
  • Low power 980 nm laser is used to treat areas with cellulites. Results are permanent because the adiposite cells are destroyed. Only in very rare exceptions, these cells are reproduced as a side effect: after the laser application, a softening of the treated area appeared to the tact and harder limiting section on the limits of the treated area. This generates a lymphatic edema produced by the body to eliminate the emulsified fat after the procedure.
  • FIGS. 1A to 1B disclose pictures before and after of the interior eyelids;
  • FIGS. 5A and 5B disclose pictures before and after of a thorax area; and
  • FIGS. 6A and 6B disclose before and after pictures of the thigh and buttock area.
  • FIG. 2 shows laser radiation device 100 having optical fiber cable 102 connected into needle-like device 104 that is for insertion into treatment area 106 .
  • Fluid pump 108 is used for inputting any fluids including the tumescent anesthetic fluid and the saline solution through line 114 into and through the needle like device 104 .
  • a fluid suction pump 116 having one or more hoses 110 with one or more suction heads 112 is placed on the entry sites to assist in the removal of liquid from the area of treatment.
  • needle like device 104 As to needle like device 104 , several embodiments are shown in FIGS. 3A and 3B as needles 300 and 302 .
  • the entry ends are appropriately finished.
  • needle 300 being in cross section has a plurality of optical fibers 304 circumferentially located about central lumen 306 which may be used for inputting fluids and for suction removal of fluids.
  • Wall 308 surrounding fibers 304 may act as a cladding and whole needle 300 may be manufactured from a single preform of material appropriately formed.
  • FIG. 3B illustrates by cross section another needle like device 302 wherein a lumen 310 is centrally located in optical fiber 312 being a core fiber without any cladding shown.
  • Appropriate cladding layer(s), buffer layer(s), and protective layer(s), although not shown, are understood to be present as needed.
  • FIG. 4 further illustrates another embodiment of a needle like device 400 wherein cannula wall 402 has central lumen 404 therein.
  • Tip area 406 is appropriately formed as a slanted wedge. Inside of lumen 404 is attached either separately or integrally formed optical fiber 408 .
  • Tip area 410 of optical fiber 406 is formed to have slanted output end 420 with mirror 412 formed thereon to cause optical radiation 414 to be output in a sidewise manner as shown between rays 416 and 418 .
  • Mirror 412 formed on tip 420 need not have a surface congruent with the surface of tip 406 of cannula wall 402 .
  • end is angled at the critical angle for reflection and the light exits fiber 406 perpendicularly to the fiber axis. Due to the closeness of the adipose tissue to the skin surface, a catheter or similar device may not be needed to guide the needle to area of treatment 106 , shown in FIG. 2 . That is only the entering needle is needed to introduce the optical fiber to the fatty area to be treated.
  • FIGS. 7A to 7F illustrate various devices for applying radiation, inputting fluids and removing fluids from an area of treatment within the body.
  • the device 700 A comprises a cannula 702 with an end 704 fitted with an applicator tip 706 A.
  • Cannula 700 has one or more lumens for holding one or more laser optical fibers 708 with a side-fire tip 710 .
  • An elongated aperture 712 is located along the traverse axis of application tip 706 A.
  • Side-fire tip 710 is positioned within lumen 714 so as to allow the radiation output from side-fire tip 710 to exist through aperture 712 .
  • the length of aperture 712 is several times the width of aperture 712 so as to allow a sufficient space for outputting and inputting fluid therethrough.
  • applicator tip 706 has a first aperture 716 for radiation output from side-fire tip 710 and a second aperture 718 for inputting and removing fluids. Further, there may be multiple apertures 718 on applicator tip 706 B and further there may be separate apertures for inputting fluid and removing fluid appropriately located about tip 706 .
  • applicator tip 706 C has one aperture 720 for the control of fluids. Located about aperture 702 are a plurality of optical fiber outputs 722 .
  • applicator tip 706 D is attached to cannula end 704 .
  • An optical fiber 724 is placed within one lumen of cannula 702 and has an output tip 726 that directly communicates with applicator tip 706 D.
  • Applicator tip 706 D is made from high quality optical silica, for example, and has a reflective coating 728 positioned on a portion of the front end 730 so as to intercept output radiation from optical fiber 724 and reflect such in a radial direction as shown.
  • Further application tip 706 D may include at least one lumen 732 therein that communicates with one lumen 734 in cannula 702 .
  • FIG. 7E discloses another embodiment where applicator tip 700 E has two laser output apertures 738 and 740 and two fluid control apertures 742 and 744 . Although this shows these located on the same side of the tip 700 E, other locations are equally feasible, for example, having the output apertures located on the opposite of the tip 700 E. Further, additional apertures may be included about the tip so as to reduce or eliminate the need for rotating the cannula 702 when outputting radiation and/or controlling fluid.
  • FIG. 7F discloses another embodiment of applicator tip 700 F where optical fiber 724 has a wedge shaped termination 746 to spread the radiation from a front end 748 .
  • One or more fluid control apertures 750 are included in applicator tip 700 E.
  • Table 1 illustrates the various parameters used in operating the diode laser of the present invention to remove excess adipose tissues in the areas noted:
  • this treatment is an out-patient alternative, minimally invasive, more elegant and with less risks and complications than current treatments. Although there is no need for hospitalization, it must be followed by a diet and physical ultrasound and lymphatic drainage. Results can be appreciated from about week 3 and final results achieved between weeks 6 and 10.
  • FIGS. 1A and 1B illustrate by photographs the before and after appearance of lower eyelids treated by the method and device of the present invention as example of effective treatment of the present invention.
  • the laser energy is delivered through a disposable fiber optic directly into the sub-dermal tissue.
  • This tissue is composed of adiposities and structural tissues irrigated by small arteries, veins and lymphatic.
  • the laser is pulsed 20 to 30 times at a power of 4 W delivering 8 Joules at 2 seconds per pulse.
  • the radiation of the Biolitec® 980 nm laser is selectively absorbed by the sub-dermal tissue which is surrounded by saline solution.
  • thermal effect (980 nm radiation is highly absorbed by water) the adipose membranes are destroyed.
  • the temperature reached on the tip of the fiber is around 100° C. which is transmitted by the tumescent anesthesia diffusing and reducing the temperature to 70° C. ⁇ 10° C. It is thus considered that a minimum temperature of 50° C. must be present to denature the cells' proteins and preferably the temperature of the cells being treated is in the range of 70° C. ⁇ 10° C. Moving the laser fiber back and forth, a 2 cm penetration with fat tissues dissociation is achieved.
  • FIGS. 5A and 5B illustrate by photographs the before and after appearance of the dorsal area treated by the method and device of the present invention as an example of effective treatment of the present invention.
  • the laser energy is delivered through a disposable fiber optic directly into the sub-dermal tissue.
  • This tissue is composed by adiposities and structural tissues irrigated by small arteries, veins and lymphatic.
  • the laser is pulsed more than 70 times at a power of 12 watts, 36 Joules at 3 seconds per pulse.
  • the radiation of the Biolitec® 980 nm laser is selectively absorbed by the sub-dermal tissue which is surrounded by saline solution.
  • thermal effect (980 nm radiation is highly absorbed by water) the adiposities membranes are destroyed.
  • the temperature reached on the tip of the fiber is around 100° C. which is transmitted by the tumescent anesthesia diffusing and reducing to 70° C. ⁇ 10° C. the temperature. It is thus considered that a minimum temperature of 50° C. should be present to denature the cells' proteins and preferably the temperature of the cells being treated is in the range of 70° C. ⁇ 10° C. Moving the laser fiber back and forth, a 2 cm penetration with fat tissues dissociation is achieved.
  • FIGS. 6A and 6B illustrate by photographs the before and after appearance of the external side of the thigh treated by the method and device of the present invention as an example of effective treatment of the present invention.
  • the radiation of the Biolitec® 980 nm laser is selectively absorbed by the sub-dermal tissue which is surrounded by saline solution.
  • thermal effect (980 nm radiation is highly absorbed by water) the adiposities membranes are destroyed.
  • the temperature reached on the tip of the fiber is around 100° C. which is transmitted by the tumescent anesthesia diffusing and reducing the temperature to 70° C. ⁇ 10° C. It is thus considered that a minimum temperature of 50° C. should be present to denature the cells' proteins and preferably the temperature of the cells being treated is in the range of 75° C. ⁇ 25° C. Moving the laser fiber back and forth, a 2 cm penetration with fat tissues dissociation is achieved.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Electromagnetism (AREA)
  • Otolaryngology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Laser Surgery Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Materials For Medical Uses (AREA)
US11/415,782 2005-05-05 2006-05-02 Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity Active 2031-07-22 US8801764B2 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US11/415,782 US8801764B2 (en) 2005-05-05 2006-05-02 Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
KR1020077026969A KR20080006623A (ko) 2005-05-05 2006-05-04 국소 지방이영양증 및 무기력증 위한 미용 레이저 치료디바이스 및 방법
JP2008510177A JP2009502212A (ja) 2005-05-05 2006-05-04 局部的なリポジストロフィー及び弛みの美容学的治療装置及び方法
BRPI0610986A BRPI0610986B8 (pt) 2005-05-05 2006-05-04 dispositivo a laser para redução de gordura e reformação de colágeno
CA2606772A CA2606772C (en) 2005-05-05 2006-05-04 Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
MX2007013851A MX2007013851A (es) 2005-05-05 2006-05-04 Metodo y dispositivo de tratamiento laser cosmetico para lipodistrofias localizadas y flacidez.
ES06759003.4T ES2533205T3 (es) 2005-05-05 2006-05-04 Dispositivo de tratamiento láser cosmético para lipodistrofias localizadas y flacidez
EP06759003.4A EP1912583B1 (en) 2005-05-05 2006-05-04 Cosmetic laser treatment device for localized lipodystrophies and flaccidity
CN2006800154094A CN101170959B (zh) 2005-05-05 2006-05-04 用于局部脂肪营养不良和松弛的整容激光治疗器械和方法
PCT/US2006/017027 WO2006121734A1 (en) 2005-05-05 2006-05-04 Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
US14/282,117 US20150005751A1 (en) 2005-05-05 2014-05-20 Cosmetic Laser Treatment Device and Method for Loacalized Lipodystrophies and Flaccidity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67809605P 2005-05-05 2005-05-05
US11/415,782 US8801764B2 (en) 2005-05-05 2006-05-02 Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/282,117 Division US20150005751A1 (en) 2005-05-05 2014-05-20 Cosmetic Laser Treatment Device and Method for Loacalized Lipodystrophies and Flaccidity

Publications (2)

Publication Number Publication Date
US20060253112A1 US20060253112A1 (en) 2006-11-09
US8801764B2 true US8801764B2 (en) 2014-08-12

Family

ID=37394994

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/415,782 Active 2031-07-22 US8801764B2 (en) 2005-05-05 2006-05-02 Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
US14/282,117 Abandoned US20150005751A1 (en) 2005-05-05 2014-05-20 Cosmetic Laser Treatment Device and Method for Loacalized Lipodystrophies and Flaccidity

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/282,117 Abandoned US20150005751A1 (en) 2005-05-05 2014-05-20 Cosmetic Laser Treatment Device and Method for Loacalized Lipodystrophies and Flaccidity

Country Status (10)

Country Link
US (2) US8801764B2 (ko)
EP (1) EP1912583B1 (ko)
JP (1) JP2009502212A (ko)
KR (1) KR20080006623A (ko)
CN (1) CN101170959B (ko)
BR (1) BRPI0610986B8 (ko)
CA (1) CA2606772C (ko)
ES (1) ES2533205T3 (ko)
MX (1) MX2007013851A (ko)
WO (1) WO2006121734A1 (ko)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019070632A1 (en) * 2017-10-02 2019-04-11 Contraline, Inc. METHOD AND APPARATUS FOR ADMINISTERING STIMULUS TO OCCLUSIVE IMPLANT
US10751124B2 (en) 2017-01-05 2020-08-25 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
US11253391B2 (en) 2018-11-13 2022-02-22 Contraline, Inc. Systems and methods for delivering biomaterials
US11904068B2 (en) 2015-11-12 2024-02-20 University Of Virginia Patent Foundation Occlusive implant compositions

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1742588B1 (en) 2004-04-01 2016-10-19 The General Hospital Corporation Apparatus for dermatological treatment and tissue reshaping
US20060047281A1 (en) 2004-09-01 2006-03-02 Syneron Medical Ltd. Method and system for invasive skin treatment
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
US8127771B2 (en) * 2005-05-18 2012-03-06 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
US8256429B2 (en) * 2005-05-18 2012-09-04 Cooltouch Incorporated Treatment of cellulite and adipose tissue with mid-infrared radiation
EP1928549B1 (en) 2005-09-28 2014-06-11 Candela Corporation Apparatus for treating cellulite
US7891362B2 (en) 2005-12-23 2011-02-22 Candela Corporation Methods for treating pigmentary and vascular abnormalities in a dermal region
US20070244529A1 (en) * 2006-04-18 2007-10-18 Zoom Therapeutics, Inc. Apparatus and methods for treatment of nasal tissue
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
US20080027423A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Systems for treatment of nasal tissue
US20080269735A1 (en) * 2007-04-26 2008-10-30 Agustina Vila Echague Optical array for treating biological tissue
WO2009042268A1 (en) * 2007-09-28 2009-04-02 Choi George Y Device and methods for treatment of tissue
US20090182315A1 (en) * 2007-12-07 2009-07-16 Ceramoptec Industries Inc. Laser liposuction system and method
KR101626167B1 (ko) 2008-01-17 2016-05-31 시네론 메디컬 리미티드 개인용 모발 제거 장치 및 그 사용 방법
US20120022512A1 (en) * 2008-01-24 2012-01-26 Boris Vaynberg Device, apparatus, and method of adipose tissue treatment
JP2011509791A (ja) 2008-01-24 2011-03-31 シネロン メディカル リミテッド 脂肪組織治療の機器、装置および方法
US20090326525A1 (en) * 2008-06-26 2009-12-31 Jessica Hixon Laser fiber capillary apparatus and method
US20120022504A1 (en) * 2008-09-11 2012-01-26 Syneron Medical Ltd. Device, apparatus, and method of adipose tissue treatment
EP2334249B1 (en) 2008-09-21 2013-03-13 Syneron Medical Ltd. A method and apparatus for personal skin treatment
ES2461619T3 (es) 2009-02-25 2014-05-20 Syneron Medical Ltd. Rejuvenecimiento eléctrico de la piel
EP2521591A4 (en) * 2010-01-08 2013-05-29 Ceramoptec Gmbh DEVICE AND METHOD FOR SKIN RADIATION TREATMENT OF FAT TISSUE
US20120289947A1 (en) * 2010-01-18 2012-11-15 Wolfgang Neuberger Device and method for removing veins
US20110282334A1 (en) * 2010-05-11 2011-11-17 Ceramoptec Industries Inc. Device and method for fistula treatment
BR112013016337A2 (pt) * 2010-12-29 2018-02-14 Biolitec Pharma Marketing Ltd sistema de tratamento médico com fibra óptica
WO2012114334A1 (en) * 2011-02-24 2012-08-30 Ilan Ben Oren Hybrid catheter for endoluminal intervention
US9066678B2 (en) * 2011-09-23 2015-06-30 Alcon Research, Ltd. Ophthalmic endoilluminators with directed light
US20140200503A1 (en) * 2013-01-17 2014-07-17 Patricio CENTURION Systems, devices, and methods for isolation of stem cells
US9979284B2 (en) 2014-02-05 2018-05-22 The Regents Of The University Of Michigan Self-oscillating switched-capacitor DC-DC converter
US10357173B2 (en) * 2015-09-14 2019-07-23 Biosense Webster (Israel) Ltd. Dual multiray electrode catheter
CN109414292A (zh) 2016-05-05 2019-03-01 爱克斯莫医疗有限公司 用于切除和/或消融不需要的组织的装置和方法
KR101940284B1 (ko) * 2016-06-29 2019-01-18 주식회사 엘림텍 고출력 레이저 치료장치
CN106109010B (zh) * 2016-08-26 2019-02-05 柳州市工人医院 医用电离子点痣笔
JP7326021B2 (ja) * 2019-05-16 2023-08-15 朝日インテック株式会社 光照射デバイス、及び、光照射システム
JP7326020B2 (ja) * 2019-05-16 2023-08-15 朝日インテック株式会社 光照射システム、カテーテル、及び、光照射デバイス
JP7340174B2 (ja) * 2019-05-16 2023-09-07 朝日インテック株式会社 光照射システム
US12038322B2 (en) 2022-06-21 2024-07-16 Eximo Medical Ltd. Devices and methods for testing ablation systems

Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538919A (en) 1967-04-07 1970-11-10 Gregory System Inc Depilation by means of laser energy
US4537193A (en) 1982-10-28 1985-08-27 Hgm, Inc. Laser endocoagulator apparatus
US4686979A (en) 1984-01-09 1987-08-18 The United States Of America As Represented By The United States Department Of Energy Excimer laser phototherapy for the dissolution of abnormal growth
US4773413A (en) 1983-06-13 1988-09-27 Trimedyne Laser Systems, Inc. Localized heat applying medical device
US4985027A (en) 1990-02-26 1991-01-15 Dressel Thomas D Soft tissue aspiration device and method
US5084043A (en) 1990-01-12 1992-01-28 Laserscope Method for performing a percutaneous diskectomy using a laser
US5102410A (en) * 1990-02-26 1992-04-07 Dressel Thomas D Soft tissue cutting aspiration device and method
US5123845A (en) 1988-08-25 1992-06-23 American Dental Laser, Inc. Dental laser assembly
US5129896A (en) 1989-11-13 1992-07-14 Hasson Harrith M Holder to facilitate use of a laser in surgical procedures
US5188632A (en) * 1984-12-07 1993-02-23 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US5334190A (en) 1990-10-16 1994-08-02 Summit Technology, Inc. Laser thermokeratoplasty methods and apparatus
US5370642A (en) 1991-09-25 1994-12-06 Keller; Gregory S. Method of laser cosmetic surgery
US5377683A (en) * 1989-07-31 1995-01-03 Barken; Israel Ultrasound-laser surgery apparatus and method
US5395361A (en) * 1994-06-16 1995-03-07 Pillco Limited Partnership Expandable fiberoptic catheter and method of intraluminal laser transmission
US5470330A (en) 1984-12-07 1995-11-28 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US5531739A (en) 1994-09-23 1996-07-02 Coherent, Inc. Method of treating veins
US5649924A (en) 1988-06-10 1997-07-22 Trimedyne, Inc. Medical device for irradiation of tissue
US5738680A (en) 1996-04-05 1998-04-14 Eclipse Surgical Technologies, Inc. Laser device with piercing tip for transmyocardial revascularization procedures
US5807385A (en) 1993-08-02 1998-09-15 Keller; Gregory S. Method of laser cosmetic surgery
US6106516A (en) 1997-10-30 2000-08-22 Sonique Surgical Systems, Inc. Laser-assisted liposuction method and apparatus
US6176854B1 (en) 1997-10-08 2001-01-23 Robert Roy Cone Percutaneous laser treatment
US6206873B1 (en) 1996-02-13 2001-03-27 El. En. S.P.A. Device and method for eliminating adipose layers by means of laser energy
US6231567B1 (en) * 1995-08-31 2001-05-15 Biolase Technology Inc. Material remover and method
US6283124B1 (en) * 2000-05-11 2001-09-04 Jeff Schleuning Versatile compression garment
US6605080B1 (en) 1998-03-27 2003-08-12 The General Hospital Corporation Method and apparatus for the selective targeting of lipid-rich tissues
US6726681B2 (en) * 1999-02-19 2004-04-27 Scimed Life Systems, Inc. Laser lithotripsy device with suction
US20060217692A1 (en) * 2003-04-03 2006-09-28 Ceramoptec Industries, Inc. Power regulated medical underskin irradiation treatment system for manual movement
US20060224148A1 (en) * 2005-04-05 2006-10-05 Cho George E System and method for laser lipolysis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572609B1 (en) * 1999-07-14 2003-06-03 Cardiofocus, Inc. Phototherapeutic waveguide apparatus
US6254597B1 (en) * 1995-08-31 2001-07-03 Biolase Technology, Inc. Tissue remover and method
US5785704A (en) * 1996-07-29 1998-07-28 Mrc Systems Gmbh Method for performing stereotactic laser surgery
US5984915A (en) * 1997-10-08 1999-11-16 Trimedyne, Inc. Percutaneous laser treatment
US6126655A (en) * 1998-08-11 2000-10-03 The General Hospital Corporation Apparatus and method for selective laser-induced heating of biological tissue
US6605079B2 (en) * 2001-03-02 2003-08-12 Erchonia Patent Holdings, Llc Method for performing lipoplasty using external laser radiation
WO2003017745A2 (en) * 2001-08-23 2003-03-06 Sciperio, Inc. Architecture tool and methods of use
CA2490725A1 (en) * 2002-06-25 2003-12-31 Ultrashape Inc. Devices and methodologies useful in body aesthetics
US20040206365A1 (en) * 2003-03-31 2004-10-21 Knowlton Edward Wells Method for treatment of tissue

Patent Citations (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538919A (en) 1967-04-07 1970-11-10 Gregory System Inc Depilation by means of laser energy
US4537193A (en) 1982-10-28 1985-08-27 Hgm, Inc. Laser endocoagulator apparatus
US4773413A (en) 1983-06-13 1988-09-27 Trimedyne Laser Systems, Inc. Localized heat applying medical device
US4686979A (en) 1984-01-09 1987-08-18 The United States Of America As Represented By The United States Department Of Energy Excimer laser phototherapy for the dissolution of abnormal growth
US5470330A (en) 1984-12-07 1995-11-28 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US5188632A (en) * 1984-12-07 1993-02-23 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US5649924A (en) 1988-06-10 1997-07-22 Trimedyne, Inc. Medical device for irradiation of tissue
US5123845A (en) 1988-08-25 1992-06-23 American Dental Laser, Inc. Dental laser assembly
US5377683A (en) * 1989-07-31 1995-01-03 Barken; Israel Ultrasound-laser surgery apparatus and method
US5129896A (en) 1989-11-13 1992-07-14 Hasson Harrith M Holder to facilitate use of a laser in surgical procedures
US5084043A (en) 1990-01-12 1992-01-28 Laserscope Method for performing a percutaneous diskectomy using a laser
US4985027A (en) 1990-02-26 1991-01-15 Dressel Thomas D Soft tissue aspiration device and method
US5102410A (en) * 1990-02-26 1992-04-07 Dressel Thomas D Soft tissue cutting aspiration device and method
US5334190A (en) 1990-10-16 1994-08-02 Summit Technology, Inc. Laser thermokeratoplasty methods and apparatus
US5370642A (en) 1991-09-25 1994-12-06 Keller; Gregory S. Method of laser cosmetic surgery
US5807385A (en) 1993-08-02 1998-09-15 Keller; Gregory S. Method of laser cosmetic surgery
US5395361A (en) * 1994-06-16 1995-03-07 Pillco Limited Partnership Expandable fiberoptic catheter and method of intraluminal laser transmission
US5531739A (en) 1994-09-23 1996-07-02 Coherent, Inc. Method of treating veins
US6231567B1 (en) * 1995-08-31 2001-05-15 Biolase Technology Inc. Material remover and method
US6206873B1 (en) 1996-02-13 2001-03-27 El. En. S.P.A. Device and method for eliminating adipose layers by means of laser energy
US5738680A (en) 1996-04-05 1998-04-14 Eclipse Surgical Technologies, Inc. Laser device with piercing tip for transmyocardial revascularization procedures
US6176854B1 (en) 1997-10-08 2001-01-23 Robert Roy Cone Percutaneous laser treatment
US6106516A (en) 1997-10-30 2000-08-22 Sonique Surgical Systems, Inc. Laser-assisted liposuction method and apparatus
US6605080B1 (en) 1998-03-27 2003-08-12 The General Hospital Corporation Method and apparatus for the selective targeting of lipid-rich tissues
US6726681B2 (en) * 1999-02-19 2004-04-27 Scimed Life Systems, Inc. Laser lithotripsy device with suction
US6283124B1 (en) * 2000-05-11 2001-09-04 Jeff Schleuning Versatile compression garment
US20060217692A1 (en) * 2003-04-03 2006-09-28 Ceramoptec Industries, Inc. Power regulated medical underskin irradiation treatment system for manual movement
US20060224148A1 (en) * 2005-04-05 2006-10-05 Cho George E System and method for laser lipolysis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Apfelberg et al., Progress Report on Multicenter Study of Laser-Assisted Liposuction, Aesth. Plast. Surg. 18:259-64 (1994).
Apfelberg, Results of Multicenter Study of Laser-Assisted Liposuction, Clinics in Plast. Surg. vol. 23, No. 4, 713-719 (1996).
Brochure for Sunlase Dental Laser, Sunrise Technologies, 1993 (pp. 1-10).
White et al., Use of the Pulsed Nd:Yag Laser for Intraoral Soft Tissue Surgery, Lasers in Surg. and Med. 11:455-461 (1991).

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11904068B2 (en) 2015-11-12 2024-02-20 University Of Virginia Patent Foundation Occlusive implant compositions
US10751124B2 (en) 2017-01-05 2020-08-25 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
WO2019070632A1 (en) * 2017-10-02 2019-04-11 Contraline, Inc. METHOD AND APPARATUS FOR ADMINISTERING STIMULUS TO OCCLUSIVE IMPLANT
US11253391B2 (en) 2018-11-13 2022-02-22 Contraline, Inc. Systems and methods for delivering biomaterials
US11318040B2 (en) 2018-11-13 2022-05-03 Contraline, Inc. Systems and methods for delivering biomaterials
US11510807B2 (en) 2018-11-13 2022-11-29 Contraline, Inc. Systems and methods for delivering biomaterials
US11951032B2 (en) 2018-11-13 2024-04-09 Contraline, Inc. Systems and methods for delivering biomaterials
US11957616B2 (en) 2018-11-13 2024-04-16 Contraline, Inc. Systems and methods for delivering biomaterials

Also Published As

Publication number Publication date
CA2606772A1 (en) 2006-11-16
BRPI0610986B8 (pt) 2021-06-22
BRPI0610986A8 (pt) 2016-10-18
CN101170959B (zh) 2010-04-21
ES2533205T3 (es) 2015-04-08
EP1912583A4 (en) 2009-11-11
BRPI0610986B1 (pt) 2018-11-27
JP2009502212A (ja) 2009-01-29
US20150005751A1 (en) 2015-01-01
CN101170959A (zh) 2008-04-30
EP1912583A1 (en) 2008-04-23
WO2006121734A1 (en) 2006-11-16
KR20080006623A (ko) 2008-01-16
EP1912583B1 (en) 2015-01-07
BRPI0610986A2 (pt) 2010-12-21
MX2007013851A (es) 2008-02-05
US20060253112A1 (en) 2006-11-09
CA2606772C (en) 2017-03-14

Similar Documents

Publication Publication Date Title
US8801764B2 (en) Cosmetic laser treatment device and method for localized lipodystrophies and flaccidity
JP6505814B2 (ja) 血管腔内治療装置
US20080269735A1 (en) Optical array for treating biological tissue
US7217265B2 (en) Treatment of cellulite with mid-infrared radiation
US6355054B1 (en) Laser system for improved transbarrier therapeutic radiation delivery
US5897549A (en) Transformation of unwanted tissue by deep laser heating of water
CA2326120C (en) Method and apparatus for the selective targeting of lipid-rich tissues
US20050015123A1 (en) Endovascular treatment of a blood vessel using a light source
US8906079B2 (en) Method/device for transdermal vascular treatment
US20110178513A1 (en) Method and device for internal tissue removal
US8709004B2 (en) Method and device for vascular treatment
US20210322099A1 (en) Vein ablation
WO2023230615A2 (en) Negative pressure laser handpiece
Boord et al. Fun with lasers
Finder 28 Fat melting devices
KR20140140726A (ko) 의료기기용 레이저 화이버

Legal Events

Date Code Title Description
AS Assignment

Owner name: CERAMOPTEC INDUSTRIES, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUAREZ, DANILO CASETRO;NEUBERGER, WOLFGANG;SIGNING DATES FROM 20050427 TO 20050428;REEL/FRAME:017859/0024

Owner name: CERAMOPTEC INDUSTRIES, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUAREZ, DANILO CASETRO;NEUBERGER, WOLFGANG;REEL/FRAME:017859/0024;SIGNING DATES FROM 20050427 TO 20050428

AS Assignment

Owner name: BIOLITEC PHARMA MARKETING LTD., MALAYSIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOLITEC, INC.;REEL/FRAME:022482/0944

Effective date: 20090331

Owner name: BIOLITEC, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CERAMOPTEC INDUSTRIES, INC.;REEL/FRAME:022482/0956

Effective date: 20090330

Owner name: BIOLITEC PHARMA MARKETING LTD.,MALAYSIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOLITEC, INC.;REEL/FRAME:022482/0944

Effective date: 20090331

Owner name: BIOLITEC, INC.,MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CERAMOPTEC INDUSTRIES, INC.;REEL/FRAME:022482/0956

Effective date: 20090330

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG, AUSTRIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOLITEC PHARMA MARKETING LTD.;REEL/FRAME:041182/0578

Effective date: 20160308

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551)

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 8